Sorry, you need to enable JavaScript to visit this website.
Skip to main content

This site is intended for U.S. healthcare professionals.

Pfizer-BioNTech COVID-19 Vaccine Medical Data

Main Navigation - External

  • Vaccine-related Topics
    • Clinical Trials
      • Vaccine Efficacy
      • Vaccine Safety
    • Real World Evidence
      • Vaccine Effectiveness
        • General Population
          • Omicron era
            • Adults
              • Primary Series(monovalent)
              • Boosters
            • Pediatrics
              • Primary Series(monovalent)
              • Boosters
          • Pre-Omicron era
            • Adults
              • Primary Series(monovalent)
              • Boosters(monovalent)
            • Pediatrics
              • Primary Series(monovalent)
        • Special Populations
          • Pregnant Women
          • Immunocompromised
          • Geriatrics
      • Vaccine Safety
        • Vaccine-Associated Myo/pericarditis
  • Studies

About IDH Menu External

  • Methodology / About

Monovalent mRNA COVID-19 vaccines are no longer authorized for emergency use in the United States. FDA and CDC guidance is to check inventory and dispose of monovalent mRNA vaccines according to state and local regulations.

Our Purpose

To provide up-to-date clinical trial and Real World Evidence from peer-reviewed publications for the Pfizer-BioNTech COVID-19 Vaccine using interactive data visualization of results and objective key summaries for vaccine-related topics. Learn More

Vector 1 View Vaccine & COVID-19 related Topics

Click on a topic below to view their key point summary

  • Clinical Trials
  • Vaccine Efficacy
  • Vaccine Safety
  • Real World Evidence
  • Vaccine Effectiveness
  • General Population
  • Omicron Era
  • Adults
  • Primary Series (monovalent)
  • Boosters
  • Monovalent
  • Bivalent(coming soon)
  • Pediatrics
  • Primary series (monovalent)
  • Boosters
  • Monovalent
  • Bivalent(coming soon)
  • Omicron Preprints
  • Pre-Omicron era
  • Adults
  • Primary series (monovalent)
  • Boosters (monovalent)
  • Pediatrics
  • Primary series (monovalent)
  • Special Populations
  • Pregnant Women
  • Immunocompromised
  • Geriatrics(coming soon)
  • Vaccine Safety
  • Vaccine-Associated Myo/pericarditis

Pfizer-BioNTech COVID-19 Vaccine, Bivalent has not been approved or licensed by FDA, but has been authorized for emergency use by FDA, under an EUA to prevent Coronavirus Disease 2019 (COVID-19) for use in individuals aged 6 months of age and older. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of the medical product under Section 564(b) (1) of the FD&C Act unless the declaration is terminated or authorization revoked sooner. Please see EUA Fact Sheets at www.cvdvaccine-us.com.

Monovalent mRNA COVID-19 vaccines are no longer authorized for emergency use in the United States. FDA and CDC guidance is to check inventory and dispose of monovalent mRNA vaccines according to state and local regulations.

Welcome to Pfizer-BioNTech COVID-19 Vaccines Medical Data

  • No cost, No sign-up required

  • Updated with peer-reviewed literature on COVID-19

  • Focus on the Pfizer-BioNTech COVID-19 Vaccine

  • Interactive

  • Key Point summaries to help understand medical data

This site is intended for US Healthcare Professionals. By selecting continue below, you acknowledge and certify that you are a US Healthcare Professional.​

Emergency uses of the Pfizer-BioNTech COVID-19 Vaccine have not been approved or licensed by FDA, but have been authorized by FDA, under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) in individuals 6 months of age and older. The emergency uses are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of the medical product under Section 564(b)(1) of the FD&C Act unless the declaration is terminated or authorization revoked sooner.

Footer Logo Biontech Footer Logo

Pfizer-BioNTech COVID-19 Vaccine Medical Data

Give Feedback

  • Privacy Policy
  • Terms and Conditions
  • Report an Adverse Event
How useful was the information you found on the Pfizer-BioNTech Medical Data website?
Rate us

Prescribing Information and Fact Sheets

Fact Sheet for Healthcare Providers Administering Vaccine: Emergency Use Authorization of Pfizer-BioNTech Covid-19 Vaccine, Bivalent (Original and Omicron BA.4/BA.5)

Prescribing Information and Fact Sheets

Fact Sheet for Healthcare Providers Administering Vaccine: Emergency Use Authorization of Pfizer-BioNTech Covid-19 Vaccine, Bivalent (Original and Omicron BA.4/BA.5)

Prescribing Information and Fact Sheets

Fact Sheet for Healthcare Providers Administering Vaccine: Emergency Use Authorization of Pfizer-BioNTech Covid-19 Vaccine, Bivalent (Original and Omicron BA.4/BA.5)

You are now leaving the Pfizer-BioNTech Medical Data website.
Links to external websites are provided as a resource to the viewer. These external websites are neither owned, endorsed, nor controlled by Pfizer Inc.
Pfizer accepts no responsibility for the content or services of a linked site. Any opinions, claims, or comments expressed on external sites should not be attributed to Pfizer.
You are now leaving the Pfizer-BioNTech Medical Data website.
Links to external websites are provided as a resource to the viewer. These external websites are neither owned, endorsed, nor controlled by Pfizer Inc.
Pfizer accepts no responsibility for the content or services of a linked site. Any opinions, claims, or comments expressed on external sites should not be attributed to Pfizer.